You are here
Prices & Quotes - UK Markets - Health Care Equipment & Services (4530)
Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.
- Change Today:
Physiomics awarded further contracts with Merck
By Iain Gilbert
Date: Friday 22 Oct 2021
LONDON (ShareCast) - (Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it had been awarded two further contracts by existing client Merck.
Physiomics said the contracts, expected to be completed by the end of 2021, involved simulations of the clinical efficacy of drug products in Merck's DNA damage/repair portfolio.
Chief executive Dr Jim Millen said: "Merck remains a key, valued client and we are pleased to be continuing to work with them on a number of important development programs."
As of 0910 BST, Physiomics shares were down 0.66 at 6.06p.
|Novacyt S.A. (CDI)||434.90p||+31.0%|
|Spectral Md Holdings, Ltd (DI) (Reg S)||40.00p||+2.6%|
|Integrated Diagnostics Holdings||$1.28||+0.6%|
|Isle of Wight Private Hospital||95.00p||+0.0%|
|Omega Diagnostics Group||26.25p||-11.0%|
|Creo Medical Group||135.50p||-6.2%|
|Induction Healthcare Group||48.50p||-4.9%|
|Spire Healthcare Group||231.00p||-3.8%|